Ophthalmology

Top Story

VIDEO: Surgeon presents phase 3 clinical trial results of Rhopressa

May 24, 2016

NEW ORLEANS — At the American Society of Cataract and Refractive Surgery meeting, L. Jay Katz, MD, FACS, discusses phase 3 clinical trial results of Aerie Pharmaceuticals' netarsudil ophthalmic solution 0.02%, also called Rhopressa, for lowering IOP in glaucoma patients.

Meeting News CoverageVideoFrom OSN Europe

VIDEO: Surgeon advocates sports ophthalmology as a subspecialty

May 24, 2016
MILAN — At OSN Italy, Rolando Toyos, MD, founder of the Sports Ophthalmology Society of America, explains why he believes that sports ophthalmology should become a…
From OSN EuropeVideo

VIDEO: Clear lens exchange with customized toric IOL in highly astigmatic post-PK patient

May 24, 2016
Clear lens exchange with customized toric IOL implantation in eyes with stable corneal topography and stable cylinder axis might be a good option to correct severe…
Global NotebookFrom OSN Europe

Anachronistic health care policies, bureaucracy limit access to therapy for macular disease in Italy

Ocular Surgery News Europe Edition, May 2016
Due to insufficient funding, dysfunctional organization and bureaucratic redundancy, patients with age-related macular degeneration and other macular diseases are often…
Meeting News Coverage

Researcher analyzes over-prescription of antibiotics for acute conjunctivitis

May 24, 2016
COLORADO SPRINGS, Colo. — Acute conjunctivitis is typically managed by all types of health care providers, not just ophthalmologists. Even though the American…
More News Headlines »
Clinical Science

Quantitative Assessment of Optic Nerve Changes in Patients With Diabetic Macular Edema Treated With Fluocinolone Acetonide Vitreous Implants

Ophthalmic Surgery, Lasers and Imaging Retina, May 2016, Volume 47 Issue 5
To evaluate glaucomatous changes in patients with diabetic macular edema (DME) treated with intravitreal implants…
More »
CME

Conducting Macular Clinical Trials in a Private Practice Environment

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology…
More »
Featured
Highlights from ASCRS

Highlights from ASCRS

Video From OSN Europe
Meeting News Coverage

VIDEO: Surgeons talk about trifocal IOLs

May 21, 2016
More »
morganatic-roan
morganatic-roan